Girentuximab (Anti-CA9 / Carbonic anhydrase 9)Girentuximab (Anti-CA9 / Carbonic anhydrase 9)
Move your mouse over image or click to enlarge

Girentuximab (Anti-CA9 / Carbonic anhydrase 9)

Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). MW:145.5 KD.
Cat# Size Price Qty Buy
A2578-1mg*25 1mg*25
£1,941.00
A2578-1mg*5 1mg*5
£647.00
A2578-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2578

Related Documents